Table 3. The relative abundance of the identified compounds/peaks differentiating UCML from HC and the regulation by imatinib.
Variable Name | Healthy control(HC) | UCML | Fold change | SCML | RCML | |||||||||||||
Mean | ± | SD | Mean | ± | SD | UCML/HC | Mean | ± | SD | Mean | ± | SD | ||||||
Pipecolate | 66738 | ± | 27812 | 191019 | ± | 150758 | 2.864 | 113166 | ± | 69717 | 164293 | ± | 105135 | * | ||||
Glutamine | 397746 | ± | 178241 | 731628 | ± | 477666 | * | 1.839 | 642994 | ± | 256423 | * | 744690 | ± | 508088 | * | ||
myo-Inositol | 2567687 | ± | 1211442 | 4224531 | ± | 2076166 | * | 1.645 | 2460364 | ± | 851377 | †† | 3201257 | ± | 2305927 | |||
Arabinose | 160888 | ± | 54011 | 263240 | ± | 134590 | ** | 1.636 | 169357 | ± | 57379 | † | 206307 | ± | 106486 | |||
Glycine | 4994510 | ± | 1934972 | 7755324 | ± | 3431521 | * | 1.553 | 5697956 | ± | 1783735 | 7589657 | ± | 3502635 | ||||
Urea§ (mmol/L) | 4.95 | ± | 0.94 | 7.38 | ± | 1.12 | * | 1.491 | 5.10 | ± | 1.21 | 7.49 | ± | 1.41 | * | |||
Ornithine | 7051554 | ± | 3092520 | 10132171 | ± | 3809942 | * | 1.437 | 9154095 | ± | 4566462 | 10755744 | ± | 5278905 | ||||
Pseudouridine | 187540 | ± | 93536 | 262470 | ± | 132366 | 1.400 | 123979 | ± | 55572 | † | 230273 | ± | 142358 | ||||
Glutamate | 486771 | ± | 129371 | 672095 | ± | 230155 | * | 1.381 | 475953 | ± | 94505 | † | 591183 | ± | 252764 | |||
Pyroglutamate | 12872691 | ± | 3860744 | 17366747 | ± | 3905589 | ** | 1.349 | 14246015 | ± | 3677287 | † | 16553496 | ± | 3610300 | * | ||
Urate | 8635673 | ± | 5325414 | 9311846 | ± | 5403118 | 1.078 | 11613451 | ± | 3705793 | 9157485 | ± | 3361998 | |||||
CPU_ DB5_RI1341_P | 66738 | ± | 27812 | 191019 | ± | 99008 | * | 2.862 | 113166 | ± | 69717 | 164293 | ± | 105135 | ||||
Citrate | 9277095 | ± | 2814476 | 7138455 | ± | 2012240 | * | −1.300 | 8736984 | ± | 1696040 | 7197272 | ± | 2641511 | ||||
alpha-Tocopherol | 808681 | ± | 165795 | 601033 | ± | 195359 | −1.345 | 683782 | ± | 282667 | 535638 | ± | 240045 | * | ||||
Linoleate | 8552168 | ± | 3885328 | 5109234 | ± | 2596822 | * | −1.400 | 6439932 | ± | 3154482 | 5584365 | ± | 3110760 | ||||
Adipate | 202105 | ± | 130022 | 135086 | ± | 105583 | −1.495 | 164819 | ± | 69713 | 168152 | ± | 82656 | |||||
HDL § (mmol/L) | 1.38 | ± | 0.33 | 0.83 | ± | 0.25 | ** | −1.663 | 1.27 | ± | 0.26 | † | 0.87 | ± | 0.39 | |||
Total cholesterol§ (mmol/L) | 4.57 | ± | 1.28 | 3.28 | ± | 1.03 | −1.393 | 3.79 | ± | 0.60 | 2.76 | ± | 0.77 | |||||
Non-esterified cholesterol | 66222510 | ± | 11227958 | 61596173 | ± | 12264833 | −1.075 | 59449993 | ± | 10150252 | 55116351 | ± | 10009437 | |||||
CPU_ DB5_RI2494_P | 4252017 | ± | 1132727 | 3208128 | ± | 1021383 | * | −1.325 | 4008764 | ± | 1149047 | † | 3019455 | ± | 826266 | ** | ‡ | |
CPU_ DB5_RI2664_P | 988481 | ± | 549499 | 648226 | ± | 389483 | * | −1.525 | 1080495 | ± | 309271 | † | 728768 | ± | 315890 | ‡ | ||
CPU_ DB5_RI2124_P | 177008 | ± | 101696 | 105477 | ± | 98053 | −1.678 | 186469 | ± | 97861 | † | 110002 | ± | 57932 |
All peaks areas were normalized by the stable isotope internal standard, [13C2]-myristic acid; CPU_ DB5_RIx_P: Unidentified compounds in plasma samples detected with DB-5 capillary column in GC/TOFMS, China Pharmaceutical university (CPU); RI, retention index; x, retention time index value; P, plasma sample.
,**: statistically significant different from that in HC, p<0.05, 0.01;
, ††: statistically significant different from that in UCML, p<0.05, 0.01;
, ‡‡: statistically significant different from that in SCML, p<0.05, 0.01.
, clinic measurement results.